Approved by the Office of Central Institutional Organization Commission, the State Food and Drug Administration (SFDA)'s Center for Drug Reevaluation now formally functions as the National Center for ADR Monitoring. The name "National Center for ADR Monitoring" will be used in drug/medical device adverse reaction (adverse event) monitoring from now on.